Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Richardson

Showing results (1-10 of 422) with videos related to

Pageof 43
Sort By:
Cancer Treatment Reviews|May 10, 2003
Clinical update: proteasome inhibitors in hematologic malignanciesPaul Richardson
Oncology (Williston Park, N.Y.)|June 16, 2006
Newer treatment options for patients in first relapse. From the Multiple Myeloma Research FoundationPaul Richardson
Clinical Advances in Hematology & Oncology : H&O|July 13, 2006
Optimizing bortezomib treatment in patients with relapsed multiple myelomaPaul Richardson
Pathophysiology of Haemostasis and Thrombosis|September 5, 2003
Hemostatic complications of hematopoietic stem cell transplantation: from hemorrhage to microangiopathies and VODPaul Richardson
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
New therapies for the treatment of multiple myelomaPaul Richardson
Seminars in Hematology|December 14, 2005
Management of the relapsed/refractory myeloma patient: strategies incorporating lenalidomidePaul Richardson
Expert Opinion on Drug Discovery|December 18, 2025
Utility of fluorinated α-amino acids in development of therapeutic peptidesPaul Richardson
Expert Opinion on Drug Discovery|October 29, 2025
Utilization of fluorinated α-amino acids in small molecule drug designPaul Richardson
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2014
Allogeneic transplantation in multiple myeloma: a potential renaissance in the era of novel therapies?Paul Richardson
Expert Opinion on Drug Discovery|August 23, 2016
Fluorination methods for drug discovery and developmentPaul Richardson
Pageof 43

Showing results (1-10 of 422) with videos related to

Sort By:
Pageof 43
Cancer Treatment Reviews|May 10, 2003
Clinical update: proteasome inhibitors in hematologic malignanciesPaul Richardson
Oncology (Williston Park, N.Y.)|June 16, 2006
Newer treatment options for patients in first relapse. From the Multiple Myeloma Research FoundationPaul Richardson
Clinical Advances in Hematology & Oncology : H&O|July 13, 2006
Optimizing bortezomib treatment in patients with relapsed multiple myelomaPaul Richardson
Pathophysiology of Haemostasis and Thrombosis|September 5, 2003
Hemostatic complications of hematopoietic stem cell transplantation: from hemorrhage to microangiopathies and VODPaul Richardson
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
New therapies for the treatment of multiple myelomaPaul Richardson
Seminars in Hematology|December 14, 2005
Management of the relapsed/refractory myeloma patient: strategies incorporating lenalidomidePaul Richardson
Expert Opinion on Drug Discovery|December 18, 2025
Utility of fluorinated α-amino acids in development of therapeutic peptidesPaul Richardson
Expert Opinion on Drug Discovery|October 29, 2025
Utilization of fluorinated α-amino acids in small molecule drug designPaul Richardson
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2014
Allogeneic transplantation in multiple myeloma: a potential renaissance in the era of novel therapies?Paul Richardson
Expert Opinion on Drug Discovery|August 23, 2016
Fluorination methods for drug discovery and developmentPaul Richardson
Pageof 43